A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE

Judit Jørgensen; Sirpa Leppä; Thomas Relander; Thomas Stauffer Larsen; Grete F Lauritzsen; Peter de Nully Brown; Susanna  Mannisto; Giorgio  Minotti; Pierantonio  Menna; Harald Holte; Knut Liestøl; Helle  Toldbod; Francesco D’Amore

A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE

Judit Jørgensen
, Sirpa Leppä
, Thomas Relander
, Thomas Stauffer Larsen
, Grete F Lauritzsen
, Peter de Nully Brown
, Susanna Mannisto
, Giorgio Minotti
, Pierantonio Menna
, Harald Holte
, Knut Liestøl
, Helle Toldbod
, Francesco D’Amore

KI, OUH, Forskningsenhed for Hæmatologi (Odense)

Rigshospitalet
Aarhus Universitetshospital
Helsinki University Hospital
Skåne University Hospital
Oslo University Hospital
University Hospital Rome

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	PB1767
Tidsskrift	EHA Learning Center
Vol/bind	2018
Status	Udgivet - 14. jun. 2018
Begivenhed	European Hematology Association 23rd congress EHA 2018 - Stockholm , Sverige Varighed: 14. jun. 2018 → 17. jun. 2018

Konference

Konference	European Hematology Association 23rd congress EHA 2018
Land/Område	Sverige
By	Stockholm
Periode	14/06/2018 → 17/06/2018

Dokumenter og links

https://learningcenter.ehaweb.org/eha/2018/stockholm/216625/f.d.amore.a.phase.ib.open.label.multicenter.trial.of.pixantrone.etoposide.html?f=menu=14*media=3*speaker=92563*browseby=8Licens: Ikke-specificeret

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Jørgensen, J., Leppä, S., Relander, T., Larsen, T. S., Lauritzsen, G. F., de Nully Brown, P., Mannisto, S., Minotti, G., Menna, P., Holte, H., Liestøl, K., Toldbod, H., & D’Amore, F. (2018). A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE. EHA Learning Center, 2018, Artikel PB1767. https://learningcenter.ehaweb.org/eha/2018/stockholm/216625/f.d.amore.a.phase.ib.open.label.multicenter.trial.of.pixantrone.etoposide.html?f=menu=14*media=3*speaker=92563*browseby=8

@article{cc21eed698f441179cc20885ba84cf0b,

title = "A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE",

author = "Judit J{\o}rgensen and Sirpa Lepp{\"a} and Thomas Relander and Larsen, \{Thomas Stauffer\} and Lauritzsen, \{Grete F\} and \{de Nully Brown\}, Peter and Susanna Mannisto and Giorgio Minotti and Pierantonio Menna and Harald Holte and Knut Liest{\o}l and Helle Toldbod and Francesco D{\textquoteright}Amore",

year = "2018",

month = jun,

day = "14",

language = "English",

volume = "2018",

journal = "EHA Learning Center",

note = "European Hematology Association 23rd congress EHA 2018 ; Conference date: 14-06-2018 Through 17-06-2018",

}

Jørgensen, J, Leppä, S, Relander, T, Larsen, TS, Lauritzsen, GF, de Nully Brown, P, Mannisto, S, Minotti, G, Menna, P, Holte, H, Liestøl, K, Toldbod, H & D’Amore, F 2018, 'A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE', EHA Learning Center, bind 2018, PB1767. <https://learningcenter.ehaweb.org/eha/2018/stockholm/216625/f.d.amore.a.phase.ib.open.label.multicenter.trial.of.pixantrone.etoposide.html?f=menu=14*media=3*speaker=92563*browseby=8>

A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE. / Jørgensen, Judit; Leppä, Sirpa; Relander, Thomas et al.
I: EHA Learning Center, Bind 2018, PB1767, 14.06.2018.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - A PHASE IB, OPEN LABEL, MULTICENTER TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20-POSITIVE TUMORS, RITUXIMAB (PREBEN) IN RELAPSED AGGRESSIVE LYMPHOMAS OF B- OR T-CELL PHENOTYPE

AU - Jørgensen, Judit

AU - Leppä, Sirpa

AU - Relander, Thomas

AU - Larsen, Thomas Stauffer

AU - Lauritzsen, Grete F

AU - de Nully Brown, Peter

AU - Mannisto, Susanna

AU - Minotti, Giorgio

AU - Menna, Pierantonio

AU - Holte, Harald

AU - Liestøl, Knut

AU - Toldbod, Helle

AU - D’Amore, Francesco

PY - 2018/6/14

Y1 - 2018/6/14

M3 - Conference abstract in journal

VL - 2018

JO - EHA Learning Center

JF - EHA Learning Center

M1 - PB1767

T2 - European Hematology Association 23rd congress EHA 2018

Y2 - 14 June 2018 through 17 June 2018

ER -